Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by educational grants from Bristol-Myers Squibb, Lilly, and Pfizer.
Target Audience: The intended audience for this activity is rheumatologists, rheumatology nurses, and other health care professionals involved in the treatment of patients with rheumatoid arthritis (RA).
Learning Objectives: Upon successful completion of this educational activity, participants should be better able to examine the immunopathogenesis and therapeutic landscape of RA and allied conditions, as well as strategies to mitigate risk from biologic and immune-based agents.
Activity Chair:
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Director of the R.J. Fasenmyer Center for Clinical Immunology
Cleveland Clinic
Cleveland, OH
Faculty:
Allan Gibofsky, MD, JD, MACR, FACP, FCLM
Professor of Medicine, Healthcare Policy and Research
Weill Medical College of Cornell University
Attending Rheumatologist
Hospital for Special Surgery
New York, NY
Jonathan Kay, MD
Timothy S. and Elaine L. Peterson Chair in Rheumatology
Professor of Medicine
University of Massachusetts Medical School
University of Massachusetts Memorial Medical Center
Worcester, MA
Reviewers:
Kevin D. Deane, MD, PhD
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 8/31/2017)
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material was originally approved for 1 year from the date of original release, August 29, 2016 to August 28, 2017. It has since been recertified for an additional year and will now expire on August 31, 2018.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must complete the pretest, review the CME content, and complete the CME posttest and the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
Steering Committee and Faculty report the following relationship(s) which are accurate at the time of original content release (August 29, 2016):
Leonard H. Calabrese, DO
Consulting Fee: GlaxoSmithKline, Janssen, Pfizer, Sanofi
Speakers Bureau: AbbVie, Bristol-Myers Squibb, Crescendo, Genentech, Janssen
Joseph E. Craft, MD
Non-CME Services Fees: Bristol-Myers Squibb, MedImmune
John J. Cush, MD
Consulting Fee: AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Janssen, Lilly, Novartis, Pfizer, UCB
Clinical Investigator: AbbVie, AstraZeneca, Celgene, Janssen, Novartis, Pfizer
Allan Gibofsky, MD, JD, MACR, FACP, FCLM
Consulting Fee: AbbVie, Celgene, Iroko Pharmaceuticals, Pfizer, Takeda
Speakers Bureau: AbbVie, Celgene, Iroko Pharmaceuticals, Pfizer
Ownership Interest: AbbVie, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, Regeneron
Jonathan Kay, MD
Consulting Fee: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim GMbH, Bristol-Myers Squibb, Elil-Lilly, Epirus Biopharmaceuticals, Genentech Inc., GlaxoSmithKline, Hospira, Janssen, Merck, Myriad, Novartis, Pfizer, Roche, Samsung Bioepis, Sandoz, UCB
Contract Research: (Paid to Institution) AbbVie, Genentech, Eli-Lilly, Pfizer, Roche
Elizabeth Kirchner, CNP, MSN
Consulting Fee: Pfizer, Sanofi
Speakers Bureau: Crescendo Bioscience
William F.C. Rigby, MD
Consulting Fee: Bristol-Myers Squibb, Lilly, Pfizer, Roche
Non-CME Services Fees: Bristol-Myers Squibb
Contracted Research: Amgen, Bristol-Myers Squibb, Pfizer, Roche
Sergio Schwartzman, MD
Consulting Fee: AbbVie, Crescendo, Epirus, Genentech, Hospira, Janssen, Novartis, Pfizer, Regeneron
Speakers Bureau: AbbVie, Crescendo, Genentech, Hospira, Janssen, Novartis, Pfizer
Ownership Interest: Amgen, Gilead, Medtronic, Pfizer
Board Member: Discus-Analytics National Psoriasis Foundation Scientific Advisory Board Member: Bioscience, Crescendo
Gregg Silverman, MD
Consulting Fee: Bristol-Myers Squibb, Genentech
Speakers Bureau: Genentech
Reviewers report the following relationship(s):
Kevin Deane, MD
Consulting Fee: Janssen
Honoraria: Medscape
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com